Literature DB >> 24084096

Gene expression profile of cytokines and chemokines in skin lesions from Brazilian Indians with localized cutaneous leishmaniasis.

Matheus Fernandes Costa-Silva1, Luciana Inácia Gomes, Olindo Assis Martins-Filho, Renata Rodrigues-Silva, Janaína de Moura Freire, Patrícia Flávia Quaresma, Marcelo Antônio Pascoal-Xavier, Tiago Antônio de Oliveira Mendes, Rogéria Serakides, Danielle Alves Gomes Zauli, Ana Carolina Campi-Azevedo, Maria Norma Melo, Célia Maria Ferreira Gontijo, Vanessa Peruhype-Magalhães, Andréa Teixeira-Carvalho.   

Abstract

Cutaneous leishmaniasis (CL) is a chronic inflammatory disease caused by dermotropic Leishmania species belonging to the Viannia subgenera, with Leishmania (V.) braziliensis considered the main agent in Brazil. After infection, a local inflammatory process is initiated, inducing the expression of several cytokine/chemokine genes. We evaluated the immunity to CL of patients living in the indigenous community Xakriabá, Minas Gerais state, Brazil, by performing detailed analyses of the mRNA expression of different cytokines and chemokines in CL lesions, considering the time evolution (recent or late). We also studied the profile of the inflammatory infiltrate by histopathological analysis. The histopathological features of recent CL lesions showed an intense inflammatory reaction, characterized by the presence of both mononuclear and polymorphonuclear cells, whereas late CL lesions exhibited a predominance of mononuclear leukocytes. The gene expression of cytokines/chemokines in skin biopsies from the CL group showed higher transcript levels of modulatory (IL10 and TGFB1), anti-inflammatory (IL4), and pro-inflammatory (TNF, IFNG, IL12B, CCL2, CCL3, CCL5, CXCL10) biomarkers in recent lesions than in late lesions. Our findings suggest that differential gene expression of cytokines and chemokines found in skin lesions from CL patients is associated with time evolution of lesions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemokines; Cutaneous leishmaniasis; Cytokines; Gene expression; Localized immune response

Mesh:

Substances:

Year:  2013        PMID: 24084096     DOI: 10.1016/j.molimm.2013.08.008

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression.

Authors:  Adriana Navas; Deninson Alejandro Vargas; Marina Freudzon; Diane McMahon-Pratt; Nancy Gore Saravia; María Adelaida Gómez
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

3.  Low frequency of LRV1 in Leishmania braziliensis strains isolated from typical and atypical lesions in the State of Minas Gerais, Brazil.

Authors:  Diego H Macedo; Armando Menezes-Neto; Jeronimo M Rugani; Ana C Rocha; Soraia O Silva; Maria N Melo; Lon-Fye Lye; Stephen M Beverley; Célia M Gontijo; Rodrigo P Soares
Journal:  Mol Biochem Parasitol       Date:  2016-08-18       Impact factor: 1.759

4.  Expression of Pro-inflammatory Genes in Lesions and Neutrophils during Leishmania major Infection in BALB/c Mice.

Authors:  Soheyla Akhzari; Hossein Rezvan; Masoud Zolhavarieh
Journal:  Iran J Parasitol       Date:  2016 Oct-Dec       Impact factor: 1.012

5.  Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil.

Authors:  João Américo Domingos; Luana Silva Soares; Larissa M Bandeira; Camila Mareti Bonin; Ana C P Vicente; Louise Zanella; Marco Antonio Moreira Puga; Inês Aparecida Tozetti; Ana Rita Coimbra Motta-Castro; Rivaldo Venâncio da Cunha
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

6.  Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake.

Authors:  Jeronimo Nunes Rugani; Célia Maria Ferreira Gontijo; Frédéric Frézard; Rodrigo Pedro Soares; Rubens Lima do Monte-Neto
Journal:  Mem Inst Oswaldo Cruz       Date:  2019-08-15       Impact factor: 2.743

7.  Humoral immunity in leishmaniasis - Prevention or promotion of parasite growth?

Authors:  Ricardo Goncalves; Stephen M Christensen; David M Mosser
Journal:  Cytokine X       Date:  2020-10-31

8.  Characterization of Differentially Abundant Proteins Among Leishmania (Viannia) braziliensis Strains Isolated From Atypical or Typical Lesions.

Authors:  Bárbara B Esteves; Marcella N Melo-Braga; Vladimir Gorshkov; Thiago Verano-Braga; Martin R Larsen; Célia M F Gontijo; Patricia F Quaresma; Helida M Andrade
Journal:  Front Cell Infect Microbiol       Date:  2022-02-15       Impact factor: 5.293

9.  Distinct plasma chemokines and cytokines signatures in Leishmania guyanensis-infected patients with cutaneous leishmaniasis.

Authors:  Tirza Gabrielle Ramos de Mesquita; José do Espírito Santo Junior; Luan Diego Oliveira da Silva; George Allan Villarouco Silva; Felipe Jules de Araújo; Suzana Kanawati Pinheiro; Herllon Karllos Athaydes Kerr; Lener Santos da Silva; Luciane Macedo de Souza; Samir Assad de Almeida; Krys Layane Guimarães Duarte Queiroz; Josué Lacerda de Souza; Cilana Chagas da Silva; Héctor David Graterol Sequera; Mara Lúcia Gomes de Souza; Anderson Nogueira Barbosa; Gemilson Soares Pontes; Marcus Vinitius de Farias Guerra; Rajendranath Ramasawmy
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

10.  miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania (Viannia) braziliensis Infection.

Authors:  Marina de Assis Souza; Eduardo Milton Ramos-Sanchez; Sandra Márcia Muxel; Dimitris Lagos; Luiza Campos Reis; Valéria Rêgo Alves Pereira; Maria Edileuza Felinto Brito; Ricardo Andrade Zampieri; Paul Martin Kaye; Lucile Maria Floeter-Winter; Hiro Goto
Journal:  Front Cell Infect Microbiol       Date:  2021-06-10       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.